Avidity Biosciences, Inc. - RNAM

Sector: Healthcare · Industry: Pharmaceutical Preparations
Website: No information yet · Social: No information yet

Company profile

Powered by TradingView

Quarter snapshot

Latest / Compare
Q1 2026 · Q4 2025
Value (USD)
Total reported value ($000)
$1.284B
QoQ value delta ($000)
-$9.572B (-88.17%)
Implied price effect (QoQ)
-3.83%
Shares
Total shares
17,804,434
QoQ shares delta
-126,984,868 (-87.7%)
Total shares held by funds (by quarter)
Shares (left)

Fund holders include prior positions carried forward until a new 13F confirms a change. Reported holders have reported a position in this security for that quarter; this is not the total number of 13F filers.

Market chart (RNAM)

Powered by TradingView
Interactive chart by TradingView.

Top holders (Q1 2026)

Top 25 only Full list
Partial Q1 2026 data: 1 holders have filed so far. Prior holders are carried forward until their next 13F confirms a change.
Manager Value ($000) Shares % of 13F
VANGUARD GROUP INC 984,520 13,649,250 0.01%
NORGES BANK 219,735 3,046,388 0.02%
KRYGER CAPITAL Ltd 75,398 1,045,320 5.82%
ANGELO GORDON & CO., L.P. 3,245 45,000 0.31%
CIBC WORLD MARKETS CORP 552 7,658 0.0%
Corsicana & Co. 236 8,000 0.15%
AlphaQuest LLC 104 1,450 0.01%
DV EQUITIES, LLC 72 1,000 0.01%
Global Retirement Partners, LLC 15 210 0.0%
COMERICA BANK 11 158 0.0%